Evaluation of the Efficacy, Tolerability and Safety of Etoricoxib (Arcoxia) in Patients With Neuropathic Pain

PHASE4UnknownINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

August 31, 2011

Study Completion Date

April 30, 2012

Conditions

Postherpetic NeuralgiaNeuralgia

Interventions

DRUG

Etoricoxib

90mg Tablet QD at 10:00a.m.

DRUG

Placebo

One tablet QD at 10:00a.m.

Trial Locations (2)

RECRUITING

MAC (UK) Neruoscience Ltd, Liverpool

RECRUITING

MAC (UK) Neuroscience Ltd, Manchester